Chas McKhann - 01 Mar 2024 Form 4 Insider Report for Silk Road Medical Inc

Role
Chief Executive Officer, Director
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
01 Mar 2024
Net transactions value
$0
Form type
4
Filing time
05 Mar 2024, 18:17:31 UTC
Previous filing
03 Nov 2023
Next filing
18 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Award $0 +110,313 +18% $0.000000 722,396 01 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2025 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.